163 related articles for article (PubMed ID: 25081374)
1. HOXD10 expression in human breast cancer.
Vardhini NV; Rao PJ; Murthy PB; Sudhakar G
Tumour Biol; 2014 Nov; 35(11):10855-60. PubMed ID: 25081374
[TBL] [Abstract][Full Text] [Related]
2. Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients.
Wolf B; Goebel G; Hackl H; Fiegl H
BMC Cancer; 2016 Oct; 16(1):821. PubMed ID: 27770790
[TBL] [Abstract][Full Text] [Related]
3. SLC35B2 expression is associated with a poor prognosis of invasive ductal breast carcinoma.
Chim-ong A; Thawornkuno C; Chavalitshewinkoon-Petmitr P; Punyarit P; Petmitr S
Asian Pac J Cancer Prev; 2014; 15(15):6065-70. PubMed ID: 25124574
[TBL] [Abstract][Full Text] [Related]
4. Expression of underglycosylated MUC1 antigen in cancerous and adjacent normal breast tissues.
Ghosh SK; Pantazopoulos P; Medarova Z; Moore A
Clin Breast Cancer; 2013 Apr; 13(2):109-18. PubMed ID: 23122537
[TBL] [Abstract][Full Text] [Related]
5. High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer.
Salhab M; Patani N; Jiang W; Mokbel K
Breast Cancer; 2012 Apr; 19(2):153-60. PubMed ID: 20972741
[TBL] [Abstract][Full Text] [Related]
6. MiR-4728-3p could act as a marker of HER2 status.
Li H; Zhou X; Zhu J; Cheng W; Zhu W; Shu Y; Liu P
Cancer Biomark; 2015; 15(6):807-14. PubMed ID: 26406406
[TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.
Makdissi FB; Machado LV; Oliveira AG; Benvenuti TT; Katayama ML; Brentani MM; Osório CA; Mourão Netto M; Lyra EC; Carvalho F; Góes JC; Folgueira MA
Braz J Med Biol Res; 2009 Dec; 42(12):1128-37. PubMed ID: 19893985
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor alpha gene expression in breast cancer tissues from the Iranian population--a pilot study.
Hosseini A; Gopalan V; Nassiri M; Ghaffarzadehgan K; Aslaminejad A; Ghovvati S; Smith RA; Lam AK
Asian Pac J Cancer Prev; 2014; 15(20):8789-91. PubMed ID: 25374208
[TBL] [Abstract][Full Text] [Related]
9. Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.
Krzeslak A; Wojcik-Krowiranda K; Forma E; Jozwiak P; Romanowicz H; Bienkiewicz A; Brys M
Pathol Oncol Res; 2012 Jul; 18(3):721-8. PubMed ID: 22270867
[TBL] [Abstract][Full Text] [Related]
10. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R
Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
[TBL] [Abstract][Full Text] [Related]
12. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of β -tubulin isotype III gene expression in breast cancer patients.
He Q; Peng B; Zhuang D; Xiao L; Zheng L; Fan Z; Zhu J; Xu B; Xu C; Zhao J; Wu L; Zhou P; Hou L; Yu F; Zhao G
Cancer Biomark; 2015; 15(6):823-31. PubMed ID: 26406408
[TBL] [Abstract][Full Text] [Related]
14. Expression of tight junction molecules in breast carcinomas analysed by array PCR and immunohistochemistry.
Tőkés AM; Szász AM; Juhász E; Schaff Z; Harsányi L; Molnár IA; Baranyai Z; Besznyák I; Zaránd A; Salamon F; Kulka J
Pathol Oncol Res; 2012 Jul; 18(3):593-606. PubMed ID: 22193974
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.
Canevari RA; Marchi FA; Domingues MA; de Andrade VP; Caldeira JR; Verjovski-Almeida S; Rogatto SR; Reis EM
Tumour Biol; 2016 Oct; 37(10):13855-13870. PubMed ID: 27485113
[TBL] [Abstract][Full Text] [Related]
16. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.
Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P
Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines.
Mobasheri MB; Shirkoohi R; Zendehdel K; Jahanzad I; Talebi S; Afsharpad M; Modarressi MH
Tumour Biol; 2015 Sep; 36(10):8201-6. PubMed ID: 25994570
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer.
Wang YY; Li L; Ye ZY; Zhao ZS; Yan ZL
World J Surg Oncol; 2015 Aug; 13():259. PubMed ID: 26311318
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of CYP1A1 expression in breast cancer.
Hafeez S; Ahmed A; Rashid AZ; Kayani MA
Asian Pac J Cancer Prev; 2012; 13(5):1757-60. PubMed ID: 22901117
[TBL] [Abstract][Full Text] [Related]
20. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.
Endo Y; Toyama T; Takahashi S; Yoshimoto N; Iwasa M; Asano T; Fujii Y; Yamashita H
Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
